Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000947871-25-000347
Filing Date
2025-03-27
Accepted
2025-03-27 16:08:27
Documents
5
Effectiveness Date
2025-03-27

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ss4589060_s8.htm S-8 43382
2 OPINION OF MCCARTHY TETRAULT LLP ss4589060_ex0501.htm EX-5.1 14287
3 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ss4589060_ex2302.htm EX-23.2 3637
4 CALCULATION OF FILING FEE TABLE ss4589060_ex107.htm EX-FILING FEES 11177
5 GRAPHIC image_001.jpg GRAPHIC 22172
  Complete submission text file 0000947871-25-000347.txt   104296
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286169 | Film No.: 25779333
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)